Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thromboembolic Disease Recurrent”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT00182247
What this trial is testing

D-Dimer and IPG for Recurrent Thrombosis (DIRECT)

Who this might be right for
Deep Vein ThrombosisPulmonary Embolism
Hamilton Health Sciences Corporation 600
Post-approval studies (Phase 4)Study completedNCT00967304
What this trial is testing

Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism

Who this might be right for
Idiopathic Venous Thromboembolism
Ottawa Hospital Research Institute 2,779
Not applicableUnknownNCT05229471
What this trial is testing

Management of Recurrent Venous Thromboembolism During Anticoagulant Treatment in Cancer Patients - a Prospective Cohort Study

Who this might be right for
CancerVenous ThromboembolismRecurrence
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 220
Large-scale testing (Phase 3)WithdrawnNCT01164540
What this trial is testing

Study on the Effect of Rosuvastatin Treatment on the Prevention of Thrombosis in Patients With Previous Thrombosis

Who this might be right for
Venous ThrombosisPulmonary Embolism
AstraZeneca 3,000
Not applicableLooking for participantsNCT07016542
What this trial is testing

Cohort for Monitoring Patients With Venous Thromboembolic Disease

Who this might be right for
Venous Thromboembolic Disease
University Hospital, Rouen 2,000
Large-scale testing (Phase 3)Study completedNCT02064439
What this trial is testing

Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism)

Who this might be right for
Pulmonary EmbolismThromboembolismThrombosis+2 more
Bayer 3,365
Large-scale testing (Phase 3)Study completedNCT05515120
What this trial is testing

Rivaroxaban Plus Aspirin to Manage Recurrent Venous Thromboembolic Events

Who this might be right for
Venous ThromboembolismAnticoagulant-induced BleedingVenous Thromboses+1 more
Instituto Mexicano del Seguro Social 58
Not applicableStudy completedNCT02297373
What this trial is testing

Clinical Predictors for Venous Thromboembolism in Patients With a History of Thrombosis (PREDICTORS)

Who this might be right for
Thromboembolic Disease RecurrentDeep Vein ThrombosisPulmonary Embolism+2 more
Ottawa Hospital Research Institute 744
Not applicableUnknownNCT01382550
What this trial is testing

Prevention of Thrombosis Recurrence in Patients With Low Circulating Levels of Antithrombin.

Who this might be right for
Venous Thrombosis
Federico II University 900
Not applicableStudy completedNCT00433602
What this trial is testing

Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors

Who this might be right for
Breast CancerColorectal CancerGastric Cancer+5 more
European Organisation for Research and Treatment of Cancer - EORTC 64
Testing effectiveness (Phase 2)UnknownNCT02679664
What this trial is testing

StAtins for Venous Event Reduction in Patients With Venous Thromboembolism Pilot Study

Who this might be right for
Venous Thromboembolism
Ottawa Hospital Research Institute 312
Large-scale testing (Phase 3)UnknownNCT00222677
What this trial is testing

Aspirin for the Prevention of Recurrent Venous Thromboembolism

Who this might be right for
Venous ThromboembolismDeep Venous ThrombosisPulmonary Embolism+1 more
University Of Perugia 70
Large-scale testing (Phase 3)Ended earlyNCT01164046
What this trial is testing

Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism

Who this might be right for
Venous ThromboembolismNeoplasms
University Medical Center Groningen 56
Not applicableUnknownNCT04042155
What this trial is testing

Real-life Clinical Outcomes of Direct Oral Anticoagulants (MACACOD)

Who this might be right for
Atrial FibrillationRecurrent Venous Thromboembolism
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 1,600
Not applicableActive Not RecruitingNCT06815874
What this trial is testing

Recurrence of Thromboembolic Venous Disease of Atypical Location (RUSE)

Who this might be right for
Venous Thromboembolism
University Hospital, Brest 300
Large-scale testing (Phase 3)Study completedNCT00439725
What this trial is testing

Once - Daily Oral Direct Factor Xa Inhibitor Rivaroxaban In The Long-Term Prevention Of Recurrent Symptomatic Venous Thromboembolism In Patients With Symptomatic Deep-Vein Thrombosis Or Pulmonary Embolism. The Einstein-Extension Study

Who this might be right for
Venous Thromboembolism
Bayer 1,197
Large-scale testing (Phase 3)Study completedNCT00000614
What this trial is testing

Prevention of Recurrent Venous Thromboembolism (PREVENT)

Who this might be right for
Cardiovascular DiseasesHeart DiseasesPeripheral Vascular Diseases+3 more
National Heart, Lung, and Blood Institute (NHLBI)
Large-scale testing (Phase 3)Looking for participantsNCT04257487
What this trial is testing

Sulodexide, VESSEL®, for the Prevention of Recurrent Venous Thromboembolism (The Jason Study)

Who this might be right for
Venous ThromboembolismAnticoagulantElderly
Arianna Anticoagulazione Foundation 1,455
Testing effectiveness (Phase 2)Study completedNCT00020189
What this trial is testing

Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck CancerThromboembolism
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Study completedNCT03285438
What this trial is testing

REduced Dose Versus Full-dose of Direct Oral Anticoagulant After uNprOvoked Venous thromboEmbolism.

Who this might be right for
Venous Thromboembolism
University Hospital, Brest 2,774
Next Page